Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alison Stopeck, Adam Brufsky, Lisa Kennedy, Sumi Bhatta, Debajyoti Bhowmik, Jacqueline Buchanan, Nicolas Despiegel & Guy Hechmati. (2020) Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States. Journal of Medical Economics 23:1, pages 37-47.
Read now
Read now
Evangelos Terpos, Aurelien Jamotte, Alexandra Christodoulopoulou, Marco Campioni, Debajyoti Bhowmik, Lisa Kennedy & Wolfgang Willenbacher. (2019) A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in four European countries: Austria, Belgium, Greece, and Italy. Journal of Medical Economics 22:8, pages 766-776.
Read now
Read now
David Henry, Roger von Moos, Jean-Jacques Body, Alex Rider, Jonathan De Courcy, Debajyoti Bhowmik, Francesca Gatta, Guy Hechmati & Yi Qian. (2019) Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in the United States. Current Medical Research and Opinion 35:3, pages 375-381.
Read now
Read now
P. Chevalier, T. Vandebrouck, D. De Keyzer, A. Mertens & M. Lamotte. (2016) Cost and co-morbidities associated with hypoglycemic inpatients in Belgium. Journal of Medical Economics 19:1, pages 44-52.
Read now
Read now
Articles from other publishers (15)
Mỹ-Vân Nguyễn, Christophe Carlier, Christophe Nich, François Gouin & Vincent Crenn. (2021) Fracture Risk of Long Bone Metastases: A Review of Current and New Decision-Making Tools for Prophylactic Surgery. Cancers 13:15, pages 3662.
Crossref
Crossref
Amelie Sas, Esther Tanck, An Sermon & G. Harry van Lenthe. (2020) Finite element models for fracture prevention in patients with metastatic bone disease. A literature review. Bone Reports 12, pages 100286.
Crossref
Crossref
Arif Ali Awan, Brian Hutton, John Hilton, Sasha Mazzarello, Catherine Van Poznak, Lisa Vandermeer, Brianne Bota, Carol Stober, Marta Sienkiewicz, Dean Fergusson, Risa Shorr & Mark Clemons. (2019) De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis. Breast Cancer Research and Treatment 176:3, pages 507-517.
Crossref
Crossref
Roger von Moos, Luis Costa, Eva Gonzalez-Suarez, Evangelos Terpos, Daniela Niepel & Jean–Jacques Body. (2019) Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody. Cancer Treatment Reviews 76, pages 57-67.
Crossref
Crossref
Yi Qian, Jorge Arellano, Francesca Gatta, Guy Hechmati, A. Brett Hauber, Ateesha F. Mohamed, Amit Bahl, Roger von Moos & Jean-Jacques Body. (2018) Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom. BMC Health Services Research 18:1.
Crossref
Crossref
Mengdi Yang, Yi Sun, Jing Sun, Zhiyu Wang, Yiyi Zhou, Guangyu Yao, Yifeng Gu, Huizhen Zhang & Hui Zhao. (2018) Differentially expressed and survival-related proteins of lung adenocarcinoma with bone metastasis. Cancer Medicine 7:4, pages 1081-1092.
Crossref
Crossref
Arif Hussain, Candice Yong, Katherine H. R. Tkaczuk, Yi Qian, Jorge Arellano, C. Daniel Mullins & Eberechukwu Onukwugha. (2018) Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer. PLOS ONE 13:3, pages e0193661.
Crossref
Crossref
Erica J. Carbone, Komal Rajpura, Brittany N. Allen, Emily Cheng, Bret D. Ulery & Kevin W.-H. Lo. (2017) Osteotropic nanoscale drug delivery systems based on small molecule bone-targeting moieties. Nanomedicine: Nanotechnology, Biology and Medicine 13:1, pages 37-47.
Crossref
Crossref
Jean-Jacques Body, Yves Pascal Acklin, Oliver Gunther, Guy Hechmati, João Pereira, Nikos Maniadakis, Evangelos Terpos, Jindrich Finek, Roger von Moos, Susan Talbot & Harm Sleeboom. (2016) Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries. Journal of Bone Oncology 5:4, pages 185-193.
Crossref
Crossref
Jean-Jacques Body, Sandra Casimiro & Luís Costa. (2015) Targeting bone metastases in prostate cancer: improving clinical outcome. Nature Reviews Urology 12:6, pages 340-356.
Crossref
Crossref
B. Tombal. (2015) Assessing the benefit of bone-targeted therapies in prostate cancer, is the devil in the end point's definition?. Annals of Oncology 26:2, pages 257-258.
Crossref
Crossref
VITO LORUSSO, IGNACIO DURAN, CRISTINA GARZON-RODRIGUEZ, DIANA LÜFTNER, AMIT BAHL, JOHN ASHCROFT, GUY HECHMATI, RACHEL WEI, EMMA THOMAS & HERBERT HOEFELER. (2014) Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational study. Molecular and Clinical Oncology 2:5, pages 701-708.
Crossref
Crossref
Candice Yong, Eberechukwu Onukwugha & C. Daniel Mullins. (2014) Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancer. Current Opinion in Oncology 26:3, pages 274-283.
Crossref
Crossref
Jean-Jacques Body. (2013) L’inhibition du RANK Ligand dans le traitement médical des métastases osseuses. Bulletin du Cancer 100:11, pages 1207-1213.
Crossref
Crossref
F. Goldwasser. (2013) Les métastases osseuses au cours des cancers broncho-pulmonaires. Revue des Maladies Respiratoires Actualités 5:5, pages 538-546.
Crossref
Crossref